April 21, 2020
A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus
Download publicationCellTalk Blog
July 2, 2024
Immune Monitoring
More infoBrochures & Infographics
January 31, 2023
Immune Monitoring
More infoCellTalk Blog
January 31, 2023
Immune Monitoring
More info